Xarelto Litigation Update

Xarelto Litigation Update

The latest update about the Xarelto litigation process is finally here. Plaintiffs from around the nation claim that Bayer’s anticoagulant medication Xarelto was defectively designed and marketed with inadequate warnings about the risk of uncontrolled bleeding. Approved by the FDA in 2011, Xarelto is prescribed to treat blood clots, deep vein thrombosis and pulmonary embolism,…